DiaMedica Announces Positive Results in Top-Line Data from the Phase II ReMEDy Acute Ischemic Stroke Study and Provides a Business Update and First Quarter 2020 Financial Results
DM199 Met Primary Safety and Tolerability Endpoints in ReMEDy Study Top-Line Data Demonstrated Therapeutic Effect…